Literature DB >> 16610164

[Treatment of hepatocellular carcinoma: hepatic resection and liver transplantation].

Alina Cenuşă1.   

Abstract

Hepatocellular carcinoma (HCC) has become a major public health problem since it's incidence is continuously growing and a high mortality is related. The programs have permitted the early detection of HCC in order to apply the curative available treatment strategies. Hepatic resection is still the elective method for non-cirrhotic patients with HCC. Tumoral postresection recurrence is frequent (60-70%) and it is represented by intrahepatic metastasis or by the development of a new tumor. Milan criteria for liver transplantation need a new extension; despite improvement in surgical technique and immunosuppression, there are still many unknown aspects regarding the selection of the patients and the time needed to find the donor for transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 16610164

Source DB:  PubMed          Journal:  Rev Med Chir Soc Med Nat Iasi        ISSN: 0048-7848


  2 in total

1.  Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy.

Authors:  Thomas J Vogl; Wolfram Schwarz; Katrin Eichler; Kathrin Hochmuth; Renate Hammerstingl; Ursula Jacob; Albert Scheller; Stephan Zangos; Matthias Heller
Journal:  J Cancer Res Clin Oncol       Date:  2006-07-21       Impact factor: 4.553

2.  Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer.

Authors:  Xue-Ping Zhou; Zhi-Wei Quan; Wen-Ming Cong; Ning Yang; Hai-Bin Zhang; Shu-Hui Zhang; Guang-Shun Yang
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.